Skip to main content
SpringerLink
Log in

Venous Disorders: Medical Management

  • Reference work entry
  • First Online:
PanVascular Medicine

  • 214 Accesses

Abstract

Medication in venous disorders is different for the superficial and deep venous systems. This is because of the different pathologies of the two systems. Furthermore, when treating thrombosis, a distinction should be made between the superficial and deep venous system. Also for the deep venous system, one should make the distinction between acute and past venous thromboembolism (VTE), treating recurrent VTE, and for how long to continue treatment. Bridging therapy is a new chapter that has been addressed the last decade. Pharmacological treatment, complementary to compression therapy in venous ulcers, is discussed. In this chapter a detailed summary of the main studies on VTE treatment and prophylaxis with their conclusions is provided for ease of reference. The new oral anticoagulants are presented in the context of both treatment and prophylaxis, and their safety is discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 649.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 549.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

Chronic venous disorder:

This term includes the full spectrum of morphological and functional abnormalities of the venous system.

Chronic venous disease:

(Any) morphological and functional abnormalities of the venous system of long duration manifested by symptoms and/or signs indicating the need for investigation and/or care.

Chronic venous insufficiency (C3–C6):

A term reserved for advanced CVD, which is applied to functional abnormalities of the venous system producing edema, skin changes, or venous ulcers.

References

  • Agnelli G, Prandoni P et al (2001) Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators. N Engl J Med 345(3):165–169

    Article  CAS  PubMed  Google Scholar 

  • Agnelli G, Prandoni P et al (2003) Extended oral anticoagulant therapy after a first episode of pulmonary embolism. Ann Intern Med 139(1):19–25

    Article  CAS  PubMed  Google Scholar 

  • Agnelli G, Bergqvist D et al (2005) Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery. Br J Surg 92(10):1212–1220

    Article  CAS  PubMed  Google Scholar 

  • Agnelli G, Buller HR et al (2013a) Oral apixaban for the treatment of acute venous thromboembolism. N Engl J Med 369(9):799–808

    Article  CAS  PubMed  Google Scholar 

  • Agnelli G, Buller HR et al (2013b) Apixaban for extended treatment of venous thromboembolism. N Engl J Med 368(8):699–708

    Article  CAS  PubMed  Google Scholar 

  • Andreozzi GM (2014) Role of sulodexide in the treatment of CVD. Int Angiol 33(3):255–262

    CAS  PubMed  Google Scholar 

  • Ansell J, Hirsh J et al (2008) Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest 133(6 Suppl):160S–198S

    Article  CAS  PubMed  Google Scholar 

  • Apixaban. Summary of product characteristics. http://www.pfizer.ca/en/our_products/products/monograph/313. Cited 17 Jan 2013

  • Barritt DW, Jordan SC (1960) Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial. Lancet 1(7138):1309–1312

    Article  CAS  PubMed  Google Scholar 

  • Basu D, Gallus A et al (1972) A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time. N Engl J Med 287(7):324–327

    Article  CAS  PubMed  Google Scholar 

  • Bauer KA, Eriksson BI et al (2001) Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery PENTAMAKS. N Engl J Med 345(18):1305–1310

    Article  CAS  PubMed  Google Scholar 

  • Bauersachs R, Berkowitz SD et al (2010) Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med 363(26):2499–2510

    Article  CAS  PubMed  Google Scholar 

  • Berge E, Abdelnoor M et al (2000) Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: a double-blind randomised study. HAEST Study Group. Heparin in Acute Embolic Stroke Trial. Lancet 355(9211):1205–1210

    Article  CAS  PubMed  Google Scholar 

  • Brandjes DP, Heijboer H et al (1992) Acenocoumarol and heparin compared with acenocoumarol alone in the initial treatment of proximal-vein thrombosis. N Engl J Med 327(21):1485–1489

    Article  CAS  PubMed  Google Scholar 

  • Brandjes DP, Buller HR et al (1997) Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis. Lancet 349(9054):759–762

    Article  CAS  PubMed  Google Scholar 

  • Buller HR, Davidson BL et al (2003) Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism. N Engl J Med 349(18):1695–1702

    Article  CAS  PubMed  Google Scholar 

  • Buller HR, Davidson BL et al (2004) Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial. Ann Intern Med 140(11):867–873

    Article  PubMed  Google Scholar 

  • Buller HR, Prins MH et al (2012) Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med 366(14):1287–1297

    Article  PubMed  Google Scholar 

  • Buller HR, Decousus H et al (2013) Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. N Engl J Med 369(15):1406–1415

    Article  PubMed  Google Scholar 

  • Cannegieter SC, Briet RFI (1994) Thromboembolic and bleeding complications in patients with medical mechanical heart valve prostheses. Circulation 94:635–641

    Article  Google Scholar 

  • Cohen AT, Spiro TE et al (2011a) Extended-duration rivaroxaban thromboprophylaxis in acutely ill medical patients: MAGELLAN study protocol. J Thromb Thrombolysis 31(4):407–416

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cohen AT, Spiro TE et al (2011b) Rivaroxaban versus enoxaparin for the prevention of venous thromboembolism in acutely ill medical patients: MAGELLAN subgroup analyses. ISTH, Kyoto

    Google Scholar 

  • Cohen A, Drost P et al (2012) The Efficacy and Safety of Pharmacological Prophylaxis of Venous Thromboembolism Following Elective Knee or Hip Replacement: Systematic Review and Network Meta-Analysis. Clin Appl Thromb Hemost 18(6):611–627

    Article  PubMed  Google Scholar 

  • Cohen AT, Spiro TE et al (2013) Rivaroxaban for thromboprophylaxis in acutely ill medical patients. The Magellan study. N Engl J Med 368(6):513–523

    Article  CAS  PubMed  Google Scholar 

  • COLUMBUS (1997) Low-molecular-weight heparin in the treatment of patients with venous thromboembolism. The Columbus Investigators. N Engl J Med 337(10):657–662

    Article  Google Scholar 

  • Comerota AJ, Throm RC et al (2000) Catheter-directed thrombolysis for iliofemoral deep venous thrombosis improves health-related quality of life. J Vasc Surg 32(1):130–137

    Article  CAS  PubMed  Google Scholar 

  • Covidien (2013) Covidien: trellis peripheral infusion system. Covidien Inc., Mansfield. Available from: http://www.covidien.com/trellis/pages.aspx. Cited 28 Nov 2013

  • Della Valle A, Sammartino G et al (2003) Prevention of postoperative bleeding in anticoagulated patients undergoing oral surgery: use of platelet-rich plasma gel. J Oral Maxillofac Surg 61(11):1275–1278

    Article  PubMed  Google Scholar 

  • Douketis JD, Arneklev K et al (2006) Comparison of bleeding in patients with nonvalvular atrial fibrillation treated with ximelagatran or warfarin. Assessment of incidence, case fatality rate, time course, anatomic sites and risk factors for bleeding. Arch Intern Med 166(8):853–859

    Google Scholar 

  • Eklof B, Perrin M et al (2009) Updated terminology of chronic venous disorders: the VEIN-TERM transatlantic interdisciplinary consensus document. J Vasc Surg 49(2):498–501

    Article  PubMed  Google Scholar 

  • EKOS (2013) EKOS Corp. Ekosonic endovascular system. EKOS Corp., Bothell. Available at: http://www.ekoscorp.com. Cited 28 Nov 2013

  • Eriksson BI, Bauer KA et al (2001) Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery PENTIFRA. N Engl J Med 345(18):1298–1304

    Article  CAS  PubMed  Google Scholar 

  • Eriksson BI, Dahl OE et al (2007a) Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial. RE-NOVATE. Lancet 370(9591):949–956

    Article  CAS  PubMed  Google Scholar 

  • Eriksson BI, Dahl OE et al (2007b) Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial. J Thromb Haemost 5(11):2178–2185

    Article  CAS  PubMed  Google Scholar 

  • Eriksson BI, Borris LC et al (2008) Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty RECORD 1. N Engl J Med 358(26):2765–2775

    Article  CAS  PubMed  Google Scholar 

  • Eriksson BI, Dahl OE et al (2011) Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II*). A randomised, double-blind, non-inferiority trial. Thromb Haemost 105(4):721–729

    Article  CAS  PubMed  Google Scholar 

  • Fuji T, Fujita S et al (2010a) Efficacy and safety of edoxaban versus enoxaparin for the prevention of venous thromboembolism following total hip arthroplasty. In: STARS J-V trial 52nd annual meeting of the American Society of Hematology, Orlando

    Google Scholar 

  • Fuji T, Wang CJ et al (2010b) Edoxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty: the STARS E-III trial. International Congress on Thrombosis, Milan

    Google Scholar 

  • Gallus A, Jackaman J et al (1986) Safety and efficacy of warfarin started early after submassive venous thrombosis or pulmonary embolism. Lancet 2(8519):1293–1296

    Article  CAS  PubMed  Google Scholar 

  • Ginsberg JS, Davidson BL et al (2009) Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery. RE-MOBILIZE. J Arthroplasty 24(1):1–9

    Article  PubMed  Google Scholar 

  • Goldhaber SZ, Leizorovicz A et al (2011) Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients. N Engl J Med 365(23):2167–2177

    Article  CAS  PubMed  Google Scholar 

  • Hirschman DR, Morby LJ (2006) A study of the safety of continued anticoagulation for cataract surgery patients. Nurs Forum 41(1):30–37

    Article  PubMed  Google Scholar 

  • Hull RD, Raskob GE et al (1990) Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis. N Engl J Med 322(18):1260–1264

    Article  CAS  PubMed  Google Scholar 

  • Hull RD, Raskob GE et al (1992) Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis. N Engl J Med 326(15):975–982

    Article  CAS  PubMed  Google Scholar 

  • Ihezue CU, Smart J et al (2005) Biopsy of the prostate guided by transrectal ultrasound: relation between warfarin use and incidence of bleeding complications. Clin Radiol 60(4):459–463; discussion 457–458

    Article  CAS  PubMed  Google Scholar 

  • Jaffer AK, Ahmed M et al (2005) Low-molecular-weight-heparins as periprocedural anticoagulation for patients on long-term warfarin therapy: a standardized bridging therapy protocol. J Thromb Thrombolysis 20(1):11–16

    Article  PubMed  Google Scholar 

  • Kahn SR, Lim W et al (2012) Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 141(2 Suppl):e195S–e226S

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kakkar AK, Brenner B et al (2008) Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial RECORD 2. Lancet 372(9632):31–39

    Article  CAS  PubMed  Google Scholar 

  • Kallio H, Paloheimo M et al (2000) Haemorrhage and risk factors associated with retrobulbar/peribulbar block: a prospective study in 1383 patients. Br J Anaesth 85(5):708–711

    Article  CAS  PubMed  Google Scholar 

  • Kalodiki E (2007) Use of intermittent pneumatic compression in the treatment of venous ulcers. Future Medicine 3(2):185–191

    Google Scholar 

  • Kalodiki E, Fareed J (2011) New and generic anticoagulants and biosimilars: safety considerations. Clin Appl Thromb Hemost 17(2):136–139

    Article  CAS  PubMed  Google Scholar 

  • Kalodiki E, Stvrtinova V et al (2012) Superficial Vein Thrombosis – A consensus statement. Int Angiol 31(3):203–16

    CAS  PubMed  Google Scholar 

  • Kearon C, Ginsberg JS et al (2006) Comparison of fixed-dose weight-adjusted unfractionated heparin and low-molecular-weight heparin for acute treatment of venous thromboembolism. JAMA 296(8):935–942

    Article  CAS  PubMed  Google Scholar 

  • Koopman MM, Prandoni P et al (1996) Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group. N Engl J Med 334(11):682–687

    Article  CAS  PubMed  Google Scholar 

  • Lassen MR, Bauer KA et al (2002) Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison EPHESUS. Lancet 359(9319):1715–1720

    Article  CAS  PubMed  Google Scholar 

  • Lassen MR, Ageno W et al (2008) Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty RECORD 3. N Engl J Med 358(26):2776–2786

    Article  CAS  PubMed  Google Scholar 

  • Lassen MR, Raskob GE et al (2009) Apixaban or enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-1). N Engl J Med 361(6):594–604

    Article  CAS  PubMed  Google Scholar 

  • Lassen MR, Gallus A et al (2010a) Apixaban versus enoxaparin for thromboprophylaxis after hip replacement. (ADVANCE-3). N Engl J Med 363(26):2487–2498

    Article  CAS  PubMed  Google Scholar 

  • Lassen MR, Raskob GE et al (2010b) Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial. Lancet 375(9717):807–815

    Article  CAS  PubMed  Google Scholar 

  • Lattimer CR, Kalodiki E et al (2012) Validation of a new duplex derived haemodynamic effectiveness score, the saphenous treatment score, in quantifying varicose vein treatments. Eur J Vasc Endovasc Surg 43(3):348–354

    Article  CAS  PubMed  Google Scholar 

  • Levine M, Gent M et al (1996) A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med 334(11):677–681

    Article  CAS  PubMed  Google Scholar 

  • Liew NC, Chang YH et al (2012) Asian venous thromboembolism guidelines: prevention of venous thromboembolism. Int Angiol 31(6):501–516

    CAS  PubMed  Google Scholar 

  • Lineaweaver W, Howard R et al (1985) Topical antimicrobial toxicity. Arch Surg 120(3):267–270

    Article  CAS  PubMed  Google Scholar 

  • Linkins LA, Choi PT et al (2003) Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis. Ann Intern Med 139(11):893–900

    Article  PubMed  Google Scholar 

  • Longstreth WT Jr, Bernick C et al (2001) Frequency and predictors of stroke death in 5,888 participants in the Cardiovascular Health Study. Neurology 56(3):368–375

    Article  PubMed  Google Scholar 

  • Lubetsky A, Olchovsky YHD et al (2003) Comparison of oral vs intravenous phytodione (vitamin K1) in patients with excessive anticoagulation: a prospective randomized controlled study. Arch Intern Med 163:2469–2473

    Article  CAS  PubMed  Google Scholar 

  • Majeed A, Hwang HG et al (2013) Management and outcomes of major bleeding during treatment with dabigatran or warfarin. Circulation 2013:30

    Google Scholar 

  • Martinelli J, Jiminez A et al (1991) Mechanical cardiac valve thrombosis: is thrombectomy justified? Circulation 84S:70S–75S

    Google Scholar 

  • Merli G, Spiro TE et al (2001) Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease. Ann Intern Med 134(3):191–202

    Article  CAS  PubMed  Google Scholar 

  • Nelson EA (2011) Venous leg ulcers. Clin Evid (Online) 2011: 1902

    Google Scholar 

  • Nicolaides AN, Breddin HK et al (2006) Prevention of venous thromboembolism. International Consensus Statement. Guidelines compiled in accordance with the scientific evidence. Int Angiol 25(2):101–161

    Google Scholar 

  • Nicolaides AN, Kakkos S et al (2014) Management of chronic venous disorders of the lower limbs: guidelines according to scientific evidence. Int Angiol 33(2):87–208

    CAS  PubMed  Google Scholar 

  • Nicolaides AN, Fareed J et al (2013) Prevention and treatment of venous thromboembolism. International Consensus Statement (guidelines according to scientific evidence). Int Angiol 32(2):111–260

    CAS  PubMed  Google Scholar 

  • Partsch H (2008) Intermittent pneumatic compression in immobile patients. Int Wound J 5(3):389–397

    Article  PubMed  Google Scholar 

  • Partsch H, Winiger J et al (2004) Compression stockings reduce occupational leg swelling. Dermatol Surg 30(5):737–743; discussion 743

    PubMed  Google Scholar 

  • Prandoni P, Carnovali M et al (2004a) Subcutaneous adjusted-dose unfractionated heparin vs fixed-dose low-molecular-weight heparin in the initial treatment of venous thromboembolism. Arch Intern Med 164(10):1077–1083

    Article  CAS  PubMed  Google Scholar 

  • Prandoni P, Lensing AW et al (2004b) Below-knee elastic compression stockings to prevent the post-thrombotic syndrome: a randomized, controlled trial. Ann Intern Med 141(4):249–256

    Article  PubMed  Google Scholar 

  • Ramli R, Abdul Rahman R (2005) Minor oral surgery in anticoagulated patients: local measures alone are sufficient for haemostasis. Singapore Dent J 27(1):13–16

    PubMed  Google Scholar 

  • Ridker PM, Goldhaber SZ et al (2003) Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. N Engl J Med 348(15):1425–1434

    Article  CAS  PubMed  Google Scholar 

  • Samama MM, Cohen AT et al (1999) A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in medical patients with Enoxaparin Study Group MEDENOX. N Engl J Med 341(11):793–800

    Article  CAS  PubMed  Google Scholar 

  • Samama CM, Vray M et al (2002) Extended venous thromboembolism prophylaxis after total hip replacement: a comparison of low-molecular-weight heparin with oral anticoagulant SACRE. Arch Intern Med 162(19):2191–2196

    Article  CAS  PubMed  Google Scholar 

  • Schulman S, Granqvist S et al (1997) The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group. N Engl J Med 336(6):393–398

    Article  CAS  PubMed  Google Scholar 

  • Schulman S, Kearon C et al (2009) Dabigatran versus warfarin in the treatment of acute venous thromboembolism. N Engl J Med 361(24):2342–2352

    Article  CAS  PubMed  Google Scholar 

  • Schulman S, Kearon C et al (2013) Extended use of dabigatran, warfarin, or placebo in venous thromboembolism. N Engl J Med 368(8):709–718

    Article  CAS  PubMed  Google Scholar 

  • Simonneau G, Sors H et al (1997) A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. The THESEE Study Group. Tinzaparine ou Heparine Standard: Evaluations dans l’Embolie Pulmonaire. N Engl J Med 337(10):663–669

    Article  CAS  PubMed  Google Scholar 

  • Sorbi D, Norton I et al (2000) Postpolypectomy lower GI bleeding: descriptive analysis. Gastrointest Endosc 51(6):690–696

    Article  CAS  PubMed  Google Scholar 

  • Syed S, Adams BB et al (2004) A prospective assessment of bleeding and international normalized ratio in warfarin-anticoagulated patients having cutaneous surgery. J Am Acad Dermatol 51(6):955–957

    Article  PubMed  Google Scholar 

  • Torn M, Rosendaal FR (2003) Oral anticoagulation in surgical procedures: risks and recommendations. Br J Haematol 123(4):676–682

    Article  PubMed  Google Scholar 

  • Tsai J, Georgiades CS et al (2006) Presumed pulmonary embolism following power-pulse spray thrombectomy of upper extremity venous thrombosis. Cardiovasc Intervent Radiol 29(4):678–680

    Article  PubMed  Google Scholar 

  • Turpie AG, Bauer KA et al (2002) Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trial PENTATHLON. Lancet 359(9319):1721–1726

    Article  CAS  PubMed  Google Scholar 

  • Turpie AG, Bauer KA et al (2007) Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double-blind comparison. J Thromb Haemost 5(9):1854–1861

    Article  CAS  PubMed  Google Scholar 

  • Turpie AG, Bauer KA et al (2009a) A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT). Thromb Haemost 101(1):68–76

    CAS  PubMed  Google Scholar 

  • Turpie AG, Lassen MR et al (2009b) Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD 4): a randomised trial. Lancet 373(9676):1673–1680

    Article  CAS  PubMed  Google Scholar 

  • Valencia IC, Falabella A et al (2001) Chronic venous insufficiency and venous leg ulceration. J Am Acad Dermatol 44(3):401–421; quiz 422–424

    Article  CAS  PubMed  Google Scholar 

  • Van Thiel D, Kalodiki E et al (2009) Interpretation of benefit-risk of enoxaparin as comparator in the RECORD program: rivaroxaban oral tablets (10 milligrams) for use in prophylaxis in deep vein thrombosis and pulmonary embolism in patients undergoing hip or knee replacement surgery. Clin Appl Thromb Hemost 15(4):389–394

    Article  PubMed  Google Scholar 

  • Wichers IM, Di Nisio M et al (2005) Treatment of superficial vein thrombosis to prevent deep vein thrombosis and pulmonary embolism: a systematic review. Haematologica 90(5):672–7

    CAS  PubMed  Google Scholar 

  • Wiegand UKL, Boguschewski D, Bonnemeier FH et al (2004) Pocket hematoma after pacemaker or implantable cardioverter defibrillator surgery: influence of patient morbidity, operation strategy, and perioperative antiplatelet/anticoagulation therapy. Chest 126(4):1177–1186

    Article  PubMed  Google Scholar 

  • Yilmaz KB, Akinci M et al (2010) Central venous catheter-associated thrombosis in the perioperative period: a frequent complication in cancer patients that can be detected early with doppler examination. Tumori 96(5):690–4

    PubMed  Google Scholar 

  • Zanon E, Martinelli F et al (2003) Safety of dental extraction among consecutive patients on oral anticoagulant treatment managed using a specific dental management protocol. Blood Coagul Fibrinolysis 14(1):27–30

    Article  CAS  PubMed  Google Scholar 

Further Reading

Download references

Author information

Authors and Affiliations

  1. Josef Pflug Laboratory, Ealing Hospital and Imperial College, SW7 2AZ, London, UK

    Evi Kalodiki

  2. Department of Thrombosis and Hemostasis, Loyola University Chicago, Chicago, IL, USA

    Evi Kalodiki

  3. Departments of Pathology and Pharmacology, Loyola University Health System, Maywood, IL, USA

    Jawed Fareed

Authors
  1. Evi Kalodiki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jawed Fareed
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Evi Kalodiki .

Editor information

Editors and Affiliations

  1. Division of Cardiovascular Disease Department of Internal Medicine, Health Care Center Bitterfeld, Bitterfeld-Wolfen, Germany

    Peter Lanzer

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Berlin Heidelberg

About this entry

Cite this entry

Kalodiki, E., Fareed, J. (2015). Venous Disorders: Medical Management. In: Lanzer, P. (eds) PanVascular Medicine. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-37078-6_223

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-37078-6_223

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-37077-9

  • Online ISBN: 978-3-642-37078-6

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation